Jonathan C Javitt - Net Worth and Insider Trading
Jonathan C Javitt Net Worth
The estimated net worth of Jonathan C Javitt is at least $3 Million dollars as of 2024-05-05. Jonathan C Javitt is the Chief Scientist, 10% Owner of NRX Pharmaceuticals Inc and owns about 1,476,833 shares of NRX Pharmaceuticals Inc (NRXP) stock worth over $3 Million. Details can be seen in Jonathan C Javitt's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jonathan C Javitt has not made any transactions after 2023-08-23 and currently still holds the listed stock(s).
Transaction Summary of Jonathan C Javitt
Jonathan C Javitt Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jonathan C Javitt owns 3 companies in total, including Brainstorm Cell Therapeutics Inc (BCLI) , NextGen Healthcare Inc (NXGN) , and NRX Pharmaceuticals Inc (NRXP) .
Click here to see the complete history of Jonathan C Javitt’s form 4 insider trades.
Insider Ownership Summary of Jonathan C Javitt
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCLI | Brainstorm Cell Therapeutics Inc | 2008-08-27 | director |
| NXGN | NextGen Healthcare Inc | 2004-09-21 | director |
| NRXP | NRX Pharmaceuticals Inc | 2023-08-23 | director & 10 percent owner & Chief Scientist |
Jonathan C Javitt Latest Holdings Summary
Jonathan C Javitt currently owns a total of 1 stock. Jonathan C Javitt owns 1,476,833 shares of NRX Pharmaceuticals Inc (NRXP) as of August 23, 2023, with a value of $3 Million.
Latest Holdings of Jonathan C Javitt
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NRXP | NRX Pharmaceuticals Inc | 2023-08-23 | 1,476,833 | 2.10 | 3,101,349 |
Holding Weightings of Jonathan C Javitt
Jonathan C Javitt Form 4 Trading Tracker
According to the SEC Form 4 filings, Jonathan C Javitt has made a total of 3 transactions in NRX Pharmaceuticals Inc (NRXP) over the past 5 years, including 2 buys and 1 sells. The most-recent trade in NRX Pharmaceuticals Inc is the acquisition of 10,000 shares on August 23, 2023, which cost Jonathan C Javitt around $33,000.
Insider Trading History of Jonathan C Javitt
- 1
Jonathan C Javitt Trading Performance
GuruFocus tracks the stock performance after each of Jonathan C Javitt's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jonathan C Javitt is 2.08%. GuruFocus also compares Jonathan C Javitt's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jonathan C Javitt within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jonathan C Javitt's insider trading performs compared to the benchmark.
Performance of Jonathan C Javitt
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -12.4 |  | | | | |
| Relative Return to S&P 500(%) | -10.32 | | | | | |
Jonathan C Javitt Ownership Network
Jonathan C Javitt Owned Company Details
What does Brainstorm Cell Therapeutics Inc do?
Who are the key executives at Brainstorm Cell Therapeutics Inc?
Jonathan C Javitt is the director of Brainstorm Cell Therapeutics Inc. Other key executives at Brainstorm Cell Therapeutics Inc include EVP & Head Global Clin Research Stacy Lindborg , Chief Medical Officer Kirk Taylor , and See Remarks Alla Patlis .
Brainstorm Cell Therapeutics Inc (BCLI) Insider Trades Summary
Over the past 18 months, Jonathan C Javitt made no insider transaction in Brainstorm Cell Therapeutics Inc (BCLI). Other recent insider transactions involving Brainstorm Cell Therapeutics Inc (BCLI) include a net purchase of 11,500 shares made by Stacy Lindborg ,
In summary, during the past 3 months, insiders sold 0 shares of Brainstorm Cell Therapeutics Inc (BCLI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Brainstorm Cell Therapeutics Inc (BCLI) were sold and 11,500 shares were bought by its insiders, resulting in a net purchase of 11,500 shares.
Brainstorm Cell Therapeutics Inc (BCLI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Brainstorm Cell Therapeutics Inc Insider Transactions
Jonathan C Javitt Mailing Address
Above is the net worth, insider trading, and ownership report for Jonathan C Javitt. You might contact Jonathan C Javitt via mailing address: 1201 North Market Street, Suite 111, Wilmington De 19801.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
